Literature DB >> 9407462

Indoxyl sulfate stimulates renal synthesis of transforming growth factor-beta 1 and progression of renal failure.

T Miyazaki1, M Ise, M Hirata, K Endo, Y Ito, H Seo, T Niwa.   

Abstract

We recently demonstrated that the administration of indoxyl sulfate (dietary protein metabolite) to 5/6-nephrectomized rats accelerated the progression of chronic renal failure by increasing the transforming growth factor (TGF)-beta 1 synthesis in the kidneys, which enhanced the renal expressions of tissue inhibitor of metalloproteinase (TIMP)-1 and type 1 collagen, leading to renal fibrosis. The aim of the present study was to clarify the mechanism by which the administration of indoxyl sulfate increases TGF-beta 1 in the kidneys of uremic rats. Since infiltrative monocytes are suggested to be an important source of TGF-beta 1 in tubulointerstitial fibrosis, we examined the effect of indoxyl sulfate administration to uremic rats on the renal gene expression of intercellular adhesion molecule (ICAM)-1, which is involved in the infiltration of monocytes to kidneys. Indoxyl sulfate administration was observed to enhance the mRNA levels of ICAM-1 as well as those of TGF-beta 1, TIMP-1 and pro alpha 1 (I) collagen in the renal cortex of 5/6-nephrectomized uremic rats. In addition, we demonstrated in vitro that the addition of indoxyl sulfate significantly increased the synthesis of TGF-beta 1 in cultured proximal tubular cells. Thus, the overload of indoxyl sulfate in uremic kidneys increased the infiltration of monocytes and directly increased the synthesis of TGF-beta 1 in proximal tubular cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9407462

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  28 in total

1.  Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress.

Authors:  Mina Yu; Young Ju Kim; Duk-Hee Kang
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-28       Impact factor: 8.237

2.  Hepatic sulfotransferase as a nephropreventing target by suppression of the uremic toxin indoxyl sulfate accumulation in ischemic acute kidney injury.

Authors:  Hideyuki Saito; Misato Yoshimura; Chika Saigo; Megumi Komori; Yui Nomura; Yuko Yamamoto; Masataka Sagata; Ayaka Wakida; Erina Chuman; Kazuhiko Nishi; Hirofumi Jono
Journal:  Toxicol Sci       Date:  2014-06-23       Impact factor: 4.849

3.  Association of indoxyl sulfate with heart failure among patients on hemodialysis.

Authors:  Xue-Sen Cao; Jun Chen; Jian-Zhou Zou; Yi-Hong Zhong; Jie Teng; Jun Ji; Zhang-Wei Chen; Zhong-Hua Liu; Bo Shen; Yu-Xin Nie; Wen-Lv Lv; Fang-Fang Xiang; Xiao Tan; Xiao-Qiang Ding
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-20       Impact factor: 8.237

4.  Carbonic-adsorbent AST-120 reduces overload of indoxyl sulfate and the plasma level of TGF-beta1 in patients with chronic renal failure.

Authors:  Shuji Iida; Keisuke Kohno; Junko Yoshimura; Seiji Ueda; Michiaki Usui; Hiroshi Miyazaki; Hidemi Nishida; Kiyoshi Tamaki; Seiya Okuda
Journal:  Clin Exp Nephrol       Date:  2006-12-20       Impact factor: 2.801

Review 5.  The Gut as a Source of Inflammation in Chronic Kidney Disease.

Authors:  Wei Ling Lau; Kamyar Kalantar-Zadeh; Nosratola D Vaziri
Journal:  Nephron       Date:  2015-05-09       Impact factor: 2.847

6.  Alleviation of cisplatin-induced acute kidney injury using phytochemical polyphenols is accompanied by reduced accumulation of indoxyl sulfate in rats.

Authors:  Masahiro Kusumoto; Hiroki Kamobayashi; Daisuke Sato; Megumi Komori; Misato Yoshimura; Akinobu Hamada; Yukimasa Kohda; Kimio Tomita; Hideyuki Saito
Journal:  Clin Exp Nephrol       Date:  2011-08-23       Impact factor: 2.801

7.  Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy.

Authors:  Hongyu Zhang; Jharna Saha; Jaeman Byun; MaryLee Schin; Matthew Lorenz; Robert T Kennedy; Matthias Kretzler; Eva L Feldman; Subramaniam Pennathur; Frank C Brosius
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-30

8.  p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.

Authors:  Björn K I Meijers; Henriette De Loor; Bert Bammens; Kristin Verbeke; Yves Vanrenterghem; Pieter Evenepoel
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-15       Impact factor: 8.237

9.  Serum Indoxyl Sulfate Associates with Postangioplasty Thrombosis of Dialysis Grafts.

Authors:  Chih-Cheng Wu; Mu-Yang Hsieh; Szu-Chun Hung; Ko-Lin Kuo; Tung-Hu Tsai; Chao-Lun Lai; Jaw-Wen Chen; Shing-Jong Lin; Po-Hsun Huang; Der-Cherng Tarng
Journal:  J Am Soc Nephrol       Date:  2015-10-09       Impact factor: 10.121

10.  Serum p-cresyl sulfate predicts cardiovascular disease and mortality in elderly hemodialysis patients.

Authors:  Cheng-Jui Lin; Chih-Kuang Chuang; Thanasekaran Jayakumar; Hsuan-Liang Liu; Chi-Feng Pan; Tuen-Jen Wang; Han-Hsiang Chen; Chih-Jen Wu
Journal:  Arch Med Sci       Date:  2013-08-08       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.